![[CLOVES syndrome] : The U.S. FDA approves Alpelisib based on a French study](https://u-paris.fr/wp-content/uploads/2022/04/julia-koblitz-4AsRcVTJYTw-unsplash-1080x675.jpg)
22 April 2022 | Press, Research
AP-HP, Inserm and Université Paris Cité extend their congratulations to Professor Guillaume Canaud’s teams at Necker-Enfants Malades Hospital (AP-HP), Necker-Enfants Malades Institute (INEM), Inserm, Institut Imagine and Université Paris Cité for their work on...
![[SARS-CoV-2] Neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies](https://u-paris.fr/wp-content/uploads/2022/04/cellules-infectées-par-omicron-1080x675.jpg)
12 April 2022 | Covid-19, Press, Research
The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of...
18 March 2022 | Campus, Institution, Press
Further to the international jury’s visit in September 2021, the January 20 hearing of the university’s delegation and its partners from Inserm and CNRS, the Prime Minister has announced the permanent labeling of Université Paris Cité as an Initiative of...
8 March 2022 | Institution, Press
Further to an internal and external survey as well as a vote by its governing bodies, Université Paris Cité has become Université Paris Cité. The new name was approved by the Ministry of Higher Education, Research and Innovation, and was adopted by a decree of the...
![[VIH] : New Antibody Function Discovered](https://u-paris.fr/wp-content/uploads/2022/02/particules-de-VIH-1080x675.jpg)
7 February 2022 | Press, Research
By applying cutting-edge microscopy techniques to in vitro virus cultures, teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université Paris Cité have discovered a new function of anti-HIV-1[1] antibodies. The scientists found that certain...
